Totally laparoscopic gastrectomy for gastric cancer: A systematic review and meta-analysis of outcomes compared with open surgery

doi:10.3748/wjg.v20.i42.15867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 42

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8041)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

530

WORD

229

HTML

4325

Figures (1-3)

230

Tables (1-6)

272

Sum=5586

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1029

Download

1426

Sum=2455

Nov 14, 2014 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Nov 14, 2014; 20(42): 15867-15878
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15867

Table 1 Summary of studies included in the meta-analysis

Ref.	Region	Study design	Year	Study period	Sample size		Level of lymphad-enectomy	Surgical extension	Reconstruction	Conversion	Mortality		Matched factors¹	Quality scores
Ref.	Region	Study design	Year	Study period	TLG	OG	Level of lymphad-enectomy	Surgical extension	Reconstruction	Conversion	TLG	OG	Matched factors¹	Quality scores
Huscher et al[25]	Italy	RCT	2005	1992-1996	30	29	D1, D2	D	B-II, R-Y	NR	3.3%	6.7%	-	3²
Pugliese et al[26]	Italy	OCS (R)	2007	2000-2005	48	99	D2	S, T	R-Y	2.1%	2.1%	3.0%	-	7
Song et al[27]	South Korea	OCS (P)	2008	2005-2006	20	20	D1 + β, D2	D	B-I, R-Y	0	0	0	-	8
Lee et al[28]	Taiwan	OCS (P)	2008	1998-2005	34	34	D2	S	B-II	2.9%	0	0	1245	9
Topal et al[29]	Belgium	OCS (R)	2008	2003-2006	38	22	D2	T	R-Y	NR	2.6%	4.5%	-	8
Strong et al[30]	United States	OCS (P)	2009	2005-2008	30	30	D2	S	B-II, R-Y	NR	0	0	1245	9
Wong et al[31]	Hong Kong	OCS (R)	2009	2001-2006	18	41	D1 + α/β, D2	D	B-II, R-Y	5.0%	0	2.4%	-	7
Chouillard et al[32]	France	OCS (P)	2010	2001-2007	51	79	D2	D, T	B-II, R-Y	6.0%	0	2.5%	-	9
Scatizzi et al[33]	Italy	OCS (P)	2011	2006-2009	30	30	D2	D	R-Y	6.7%	0	0	12345	9
Moisan et al[34]	Chile	OCS (R)	2012	2005-2010	31	31	D1 + α/β, D2	S, T	B-II, R-Y	3.2%	0	0	1245	9
Cianchi et al[35]	Italy	OCS (P)	2012	2008-2012	41	41	D1 + α/β, D2	S, T	B-II, R-Y	0	2.4%	4.9%	1245	8
Siani et al[36]	Italy	OCS (R)	2012	2003-2009	25	25	D1 + α/β, D2	T	R-Y	0	0	0	145	9
Shinohara et al[37]	Japan	OCS (P)	2013	1998-2008	186	123	D2	D, P, T	B-I, R-Y	2.2%	1.1%	0	12345	9
Kim et al[38]	South Korea	OCS (P)	2013	2011	139	207	D2	T	R-Y	0	0	0	-	7

¹Jadad scores;

²Factors matched between groups: 1: Age; 2: Sex; 3: Body mass index; 4: Stage; 5: Type of gastrectomy. RCT: Randomized controlled trial; OCS: Observational clinical study; P: Prospectively collected data; R: Retrospectively collected data; TLG: Totally laparoscopic gastrectomy; OG: Open gastrectomy; D: Distal gastrectomy; P: Proximal gastrectomy; T: Total gastrectomy; S: Subtotal gastrectomy; B-I: Billroth-I; B-II: Billroth-II; R-Y: Roux-en-Y; NR: Not reported.

Table 2 Outcomes of included studies

Ref.	Operation time	Blood loss	Transfusion	RLN	Proximal margin	Distal margin	Analgesic use	Ambulation	Flatus	Oral intake	Hospital stay	Morbidity	Mortality	Survival
Huscher et al[25]	Y	Y		Y						Y	Y	Y	Y	Y
Pugliese et al[26]	Y	Y		Y			Y¹	Y	Y	Y	Y	Y	Y
Song et al[27]	Y	Y		Y	Y	Y	Y²		Y	Y	Y	Y	Y
Lee et al[28]	Y	Y		Y			Y²		Y		Y	Y	Y
Topal et al[29]	Y	Y										Y	Y
Strong et al[30]	Y	Y		Y			Y¹				Y	Y	Y	Y
Wong et al[31]	Y	Y		Y							Y	Y	Y	Y
Chouillard et al[32]	Y	Y	Y	Y							Y	Y	Y	Y
Scatizzi et al[33]	Y			Y			Y¹	Y	Y	Y	Y	Y	Y	Y
Moisan et al[34]	Y	Y	Y	Y		Y				Y	Y	Y	Y	Y
Cianchi et al[35]	Y	Y		Y					Y	Y	Y	Y	Y
Siani et al[36]	Y	Y		Y					Y		Y	Y	Y	Y
Shinohara et al[37]	Y	Y	Y	Y				Y		Y	Y	Y	Y	Y
Kim et al[38]	Y			Y	Y	Y	Y²		Y	Y	Y	Y	Y

¹Reported days of analgesic use;

²Reported days and amount of analgesic use. Y: Yes; RLN: Retrieved lymph nodes.

Table 3 Pooled short-term outcomes

Outcomes	No. of studies	Sample size		Heterogeneity	Overall effect size	95%CI of overall effect	P value
Outcomes	No. of studies	TLG	OG	(P value, I²)	Overall effect size	95%CI of overall effect	P value
Operation time (min)	14	721	811	< 0.001, 97%	WMD = 58.04	37.77-78.32	< 0.001
Blood loss (mL)	12	552	574	< 0.001, 87%	WMD = -167.57	-208.79-(-126.34)	< 0.001
Transfusion	3	268	233	0.11, 54%	RR = 0.49	0.21-1.11	0.09
Retrieved lymph nodes	13	683	789	0.04, 46%	WMD = -0.48	-2.21-1.26	0.59
Proximal margin (cm)	2	159	227	0.03, 80%	WMD = 0.00	-1.47-1.46	1.00
Distal margin (cm)	3	190	258	0.03, 70%	WMD = 0.94	-0.76-(2.64)	0.28
Analgesics given (d)	3	108	159	0.33, 11%	WMD = -1.79	-2.37-(-1.21)	< 0.001
Time to ambulation (d)	3	264	252	< 0.001, 93%	WMD = -0.91	-1.65-(-0.16)	0.02
Time to first flatus (d)	7	337	456	< 0.001, 98%	WMD = -1.97	-3.18-(-0.77)	0.001
Time to oral intake (d)	8	525	580	< 0.001, 96%	WMD = -2.39	-3.34-(-1.45)	< 0.001
Hospital stay (d)	13	683	789	< 0.001, 83%	WMD = -3.75	-4.88-(-2.63)	< 0.001
Overall complications	14	721	811	0.74, 0%	RR = 0.71	0.58-0.86	< 0.001
Surgical complications	12	635	690	0.76, 0%	RR = 0.75	0.57-0.98	0.03
Medical complications	11	615	670	0.97, 5%	RR = 0.57	0.38-0.86	0.008
Mortality	7	412	434	0.96, 0%	RR = 0.65	0.24-1.76	0.40

WMD: Weighted mean difference; RR: Risk ratio; TLG: Totally laparoscopic gastrectomy; OG: Open gastrectomy.

Table 4 Subgroup analysis of learning curve using a cut-point of 40 totally laparoscopic gastrectomy cases

Outcomes	No. of studies	Sample size		Heterogeneity	Overall effect size	95%CI of overall effect	P value
Outcomes	No. of studies	TLG	OG	(P value, I²)	Overall effect size	95%CI of overall effect	P value
Operation time (min)
< 40 TLG cases	9	256	262	< 0.001, 92%	WMD = 60.54	35.64-85.45	< 0.001
> 40 TLG cases	5	465	549	< 0.001, 99%	WMD = 53.91	16.74-91.08	0.004
Blood loss (mL)
< 40 TLG cases	8	226	232	< 0.001, 84%	WMD = -155.04	-133.22	< 0.001
> 40 TLG cases	4	326	342	< 0.001, 85%	WMD = -194.81	-95.98	< 0.001
Retrieved lymph nodes
< 40 TLG cases	8	218	240	0.23, 25%	WMD = -1.41	-6.11	0.37
> 40 TLG cases	5	465	549	0.06, 63%	WMD = 0.03	-4.27	0.98

TLG: Totally laparoscopic gastrectomy; OG: Open gastrectomy; WMD: Weighted mean difference.

Table 5 Systematic review of postoperative complications and reoperation n (%)

Ref.	Group	n	Total events	Leakage	Stenosis	Pulmonary	Wound	Pancreatitis	Obstruction	Cardiovascular	Bleeding	Abscess	Other	Reoperation
Huscher et al[25]	TLG	30	7			4	2	1						NR
Huscher et al[25]	OG	29	8	1		5	2							NR
Pugliese et al[26]	TLG	48	61	2		3								NR
Pugliese et al[26]	OG	99	141	3										NR
Song et al[27]	TLG	20	1								1			0
Song et al[27]	OG	20	1					1						0
Lee et al[28]	TLG	34	7	1			1		3		1	1		2
Lee et al[28]	OG	34	6	2		1	2		1					0
Topal et al[29]	TLG	38	151	2		1		1	3					6
Topal et al[29]	OG	22	91											0
Strong et al[30]	TLG	30	8	1			1	1	3	1	1			NR
Strong et al[30]	OG	30	13	1		1	3		4	1		2	1	NR
Wong et al[31]	TLG	18	3	1			1					1		NR
Wong et al[31]	OG	41	8	3		2			1		1	1		NR
Chouillard et al[32]	TLG	51	91	2
Chouillard et al[32]	OG	79	201	4
Scatizzi et al[33]	TLG	30	2	2										1
Scatizzi et al[33]	OG	30	8	1		3				1	1		2	1
Moisan et al[34]	TLG	31	7	4		1					1		1	4
Moisan et al[34]	OG	31	4	2									2	4
Cianchi et al[35]	TLG	41	9	2	1	1		2		1	1		1	3
Cianchi et al[35]	OG	41	14	4		5			1	2			2	2
Siani et al[36]	TLG	25	4	1		1							2	NR
Siani et al[36]	OG	25	5			2	2			1				NR
Shinohara et al[37]	TLG	186	441	5	4		2	12				9		8
Shinohara et al[37]	OG	123	431	5	5		10	8				9		2
Kim et al[38]	TLG	139	14	1	2	2	1		3		3		2	5
Kim et al[38]	OG	207	45	1	4	9	12		2		2	11	4	NR
Total (%)	TLG	721	136	24 (3.4)	7 (1.9)	13 (2.8)	8 (1.7)	17 (4.5)	12 (4.0)	2 (1.6)	8 (2.3)	11 (2.7)	6 (2.0)
Total (%)	OG	811	198	27 (3.4)	9 (2.4)	28 (4.8)	31 (6.3)	9 (3.0)	9 (2.4)	5 (4.0)	4 (0.9)	23 (5.3)	11 (3.0)
P value				0.99	0.63	0.003	< 0.001	0.32	0.23	0.45	0.11	0.06	0.42

¹Some complications were not speciﬁed. NR: Not reported; TLG: Totally laparoscopic gastrectomy; OG: Open gastrectomy.

Table 6 Systematic review of long-term survival

Ref.	Group	Follow-up (mo)	Recurrence	Survival rate (%)
Huscher et al[25]	TLG	60 (2-88)	11	5-yr DFS: 57.3, 5-yr OS: 58.9
Huscher et al[25]	OG	55 (7-90)	10	5-yr DFS: 54.8, 5-yr OS: 55.7
Lee et al[28]	TLG	NR¹	2	NR
Lee et al[28]	OG	NR¹	1	NR
Song et al[27]	TLG	11	4	NR²
Song et al[27]	OG	13.8	5	NR²
Wong et al[31]	TLG	32 (2-79)	2	5-yr OS: 81.0
Wong et al[31]	OG	27 (1-79)	9	5-yr OS: 67.5
Chouillard et al[32]	TLG	29 (12-74)	NR	OS, 1-yr: 88.4, 2-yr: 71.2, 3-y: 43.2
Chouillard et al[32]	OG	33 (14-79)	NR	OS, 1-yr: 88.3, 2-yr: 54.8, 3-yr: 38.4
Scatizzi et al[33]	TLG	18 (2-37)	NR	42-mo OS: 70.9
Scatizzi et al[33]	OG	18 (7-42)	NR	42-mo OS: 56.8
Moisan et al[34]	TLG	28	5	3-yr DFS: 79.4, 3-yr OS: 82.3
Moisan et al[34]	OG	40	4	3-yr DFS: 83.4, 3-yr OS: 86.9
Siani et al[36]	TLG	32.6	NR	5-yr DFS: 54.2, 5-yr OS: 55.7
Siani et al[36]	OG	31.9	NR	5-yr DFS: 52.1, 5-yr OS: 52.9
Shinohara et al[37]	TLG	48.8(25-58.5)^a	53	5-yr DFS: 65.8^b, 5-yr OS: 68.1^b
Shinohara et al[37]	OG	48.8(25-58.5)^a	34	5-yr DFS: 62.0^b, 5-yr OS: 63.7^b

¹All patients were followed up for at least 2 years;

²DFS at 36 mo demonstrated no signiﬁcant difference between the groups. Follow-up time was shown as median (range); a: Shown as interquartile range; b: Calculated by excluding stage IA and missed follow-up patients. DFS: Disease-free survival; OS: Overall survival; NR: Not reported.

Citation: Chen K, Pan Y, Cai JQ, Xu XW, Wu D, Mou YP. Totally laparoscopic gastrectomy for gastric cancer: A systematic review and meta-analysis of outcomes compared with open surgery. World J Gastroenterol 2014; 20(42): 15867-15878
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15867.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15867